Reina N Fuji

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Magnetic Resonance Imaging

Artificial Intelligence

Top Venues

Toxicologic pathology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mei-Lan Chu, Xing-Yue M Ge, Jeffrey Eastham, Trung Nguyen, Reina N Fuji, Ruth Sullivan, Daniel Ruderman
Assessment of Color Reproducibility and Mitigation of Color Variation in Whole Slide Image Scanners for Toxicologic Pathology. Toxicologic pathology (2024)
Mei-Lan Chu, Xing-Yue M Ge, Jeffrey Eastham, Trung Nguyen, Reina N Fuji, Ruth Sullivan, Daniel Ruderman
Assessment of Color Reproducibility and Mitigation of Color Variation in Whole Slide Image Scanners for Toxicologic Pathology. Toxicologic pathology 51 (6) (2024)
Mei-Lan Chu, Xing-Yue M Ge, Jeffrey Eastham, Trung Nguyen, Reina N Fuji, Ruth Sullivan, Daniel Ruderman
Assessment of Color Reproducibility and Mitigation of Color Variation in Whole Slide Image Scanners for Toxicologic Pathology. Toxicologic pathology 51 (6) (2024)
Mei-Lan Chu, Xing-Yue M Ge, Jeffrey Eastham, Trung Nguyen, Reina N Fuji, Ruth Sullivan, Daniel Ruderman
Assessment of Color Reproducibility and Mitigation of Color Variation in Whole Slide Image Scanners for Toxicologic Pathology. Toxicologic pathology 51 (6) (2024)
Marco A S Baptista, Kalpana Merchant, Edward G Barrett, Sakshi Bhargava, Dianne K Bryce, J Michael Ellis, Anthony A Estrada, Matthew J Fell, Brian K Fiske, Reina N Fuji, Paul Galatsis, Anastasia G Henry, Sue Hill, Warren Hirst, Christopher D Houle, Matthew E Kennedy, Xingrong Liu, Matthew L Maddess, Carrie Markgraf, Hong Mei, William A Meier, Elie Needle, Stephen Ploch, Christopher Royer, Karin Rudolph, Alok K Sharma, Antonia Stepan, Stefan Steyn, Craig Trost, Zhizhang Yin, Hongshi Yu, Xiang Wang, Todd B Sherer
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits. Science translational medicine 12 (540) (2021)
Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson, Corinne Foo-Atkins, Jasvinder K Atwal, Mira Blendstrup, Helen Booler, Joseph Bravo, Robert Brendza, Flavia Brunstein, Ruby Chan, Priya Chandra, Jessica A Couch, Akash Datwani, Barthélemy Demeule, Danielle DiCara, Rich Erickson, James A Ernst, Oded Foreman, Dongping He, Isidro Hötzel, Michael Keeley, Michael C M Kwok, Julien Lafrance-Vanasse, Han Lin, Yanmei Lu, Wilman Luk, Paul Manser, Andreas Muhs, Hai Ngu, Andrea Pfeifer, Maria Pihlgren, Gautham K Rao, Kimberly A Scearce-Levie, Stephen P Schauer, William B Smith, Hilda Solanoy, Edmond Teng, Kristin R Wildsmith, Daniela Bumbaca Yadav, Yong Ying, Reina N Fuji, Geoffrey A Kerchner
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease. Science translational medicine 13 (593) (2021)